BrightSpring CFO sells 35K shares, exercises options

BrightSpring Health Services Chief Financial Officer Jennifer A. Phipps sold 35,000 shares of common stock at $58.75 per share in an open-market transaction pursuant to a registered public offering that closed on June 5, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

BrightSpring Health Services Chief Financial Officer Jennifer A. Phipps sold 35,000 shares of common stock at $58.75 per share in an open-market transaction pursuant to a registered public offering that closed on June 5, 2026. On the same day, she exercised stock options to acquire 35,000 common shares at an exercise price of $6.37 per share. After these transactions, she directly holds 250,224 shares of common stock and 55,708 stock options that are fully vested and exercisable until September 24, 2029.

Insider Trade Summary

Exercise and Sale: 35,000 shares ($1.83M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Phipps Jennifer A

Role Chief Financial Officer

Sold 35,000 shs ($2.06M)

Approx. gross sale proceeds $2.06M

Approx. exercise cost $223K

Approx. pre-tax spread $1.83M

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy)	35,000	$0.00	$0.00
Exercise	Common Stock	35,000	$6.37	$223K
Sale	Common Stock	35,000	$58.75	$2.06M

Holdings After Transaction: Stock Options (Right to Buy) — 55,708 contracts (Direct); Common Stock — 250,224 shares (Direct)

Footnotes (2)

F1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions.
F2. These options are fully vested.

Key Figures

Shares sold: 35,000 shares Sale price: $58.75 per share Options exercised: 35,000 shares +4 more

7 metrics

Shares sold 35,000 shares Common stock sale on June 5, 2026

Sale price $58.75 per share Registered public offering closing June 5, 2026

Options exercised 35,000 shares Stock options exercised on June 5, 2026

Option exercise price $6.37 per share Stock options (Right to Buy)

Shares held after 285,224 shares Direct common stock ownership following transactions

Remaining options 55,708 options Stock options outstanding after exercise

Option expiration September 24, 2029 Remaining stock options expiry date

Key Terms

registered public offering, Stock Options (Right to Buy), Exercise or conversion of derivative security, Chief Financial Officer

4 terms

registered public offering regulatory

"shares of the Issuer's common stock were sold ... pursuant to a registered public offering"

A registered public offering is when a company files required documents with regulators to sell new shares or bonds to the general public, providing standardized financial and business information for transparency. For investors, it matters because it creates an opportunity to buy newly issued securities while often increasing market liquidity, but it can also dilute existing ownership and affect share price as supply and company funding needs change—think of a bakery baking extra loaves that can satisfy more customers but slightly reduces each owner's slice of the original batch.

Stock Options (Right to Buy) financial

"security_title": "Stock Options (Right to Buy)""

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

Chief Financial Officer financial

"officer_title": "Chief Financial Officer""

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BrightSpring (BTSG) CFO Jennifer Phipps report?

BrightSpring CFO Jennifer Phipps reported selling 35,000 shares of common stock and exercising options for 35,000 shares. Both transactions occurred on June 5, 2026, and involved common stock of BrightSpring Health Services, Inc.

How many BrightSpring (BTSG) shares did the CFO sell and at what price?

Jennifer Phipps sold 35,000 shares of BrightSpring common stock at $58.75 per share. The sale took place as part of a registered public offering that closed on June 5, 2026, before underwriting discounts and commissions.

Did the BrightSpring (BTSG) CFO exercise stock options in this Form 4 filing?

Yes. Jennifer Phipps exercised stock options to acquire 35,000 shares of BrightSpring common stock at a $6.37 exercise price. These options were fully vested, and the exercise coincided with the same date as the reported share sale.

How many BrightSpring (BTSG) shares does the CFO hold after these transactions?

Following the transactions, Jennifer Phipps directly holds 285,224 shares of BrightSpring common stock. This figure reflects her updated equity position after the 35,000-share sale and the corresponding option exercise reported in the Form 4 filing.

What stock options remain for the BrightSpring (BTSG) CFO after exercising 35,000 options?

After exercising 35,000 options, Jennifer Phipps holds 55,708 remaining stock options. These options are fully vested, carry a $6.37 exercise price, and are scheduled to expire on September 24, 2029, according to the Form 4 details.

Was the BrightSpring (BTSG) CFO’s sale part of a registered public offering?

Yes. The 35,000 shares of BrightSpring common stock sold by Jennifer Phipps were disposed of pursuant to a registered public offering that closed on June 5, 2026, at $58.75 per share before underwriting discounts and commissions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/05/2026 - 04:07 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phipps Jennifer A

(Last)

(First)

(Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE

KENTUCKY

40222

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/05/2026		M		35,000	A	$6.37	285,224	D
Common Stock	06/05/2026		S⁽¹⁾		35,000	D	$58.75⁽¹⁾	250,224	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (Right to Buy)	$6.37	06/05/2026		M			35,000	⁽²⁾	09/24/2029	Common Stock	35,000	$0	55,708	D

Explanation of Responses:

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions.

2. These options are fully vested.

	/s/ Jennifer Phipps	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR